河北天成药业股份有限公司

Established in 1970 as a state-owned manufacturer, Hebei Tiancheng Pharma has nearly 50 years’ professional experience of pharmaceuticals. Hebei Tiancheng Pharma was reorganized into the limited liability company in March 2010, is the largest comprehensive chemical pharmaceutical enterprise in Cangzhou City and also High-tech Enterprise of Hebei Province. The products of different dosage formulations sell well in domestic markets as well as CIS, Central Asia, Southeast Asia, South America, Africa and other foreign countries. More than 160 of registration certificates have been approved in different foreign countries.

Currently there is more than 1000 work staff including a number of professional talents. The annual output of infusion products can reach 350 million bottles, glass ampoule small volume injection products 400 million ampoules, plastic ampoule small volume injection products 40 million ampoules, powder for injection products 30 million ampoules, granules 300 million bags, 1.5 billion tablets and 1,400 tons traditional Chinese medicine extract. With our enterprise principle “Manufacturing good medicine for people”, Hebei Tiancheng Pharma has established its strategic development framework in pattern of pharmaceutical group, containing TIANCHENG PHARMA as the generic drug factory, DAWN PHARMA as the oncology manufacturer, NUOTE PHARMA as API factory, TIANJIN YINGTIANCHENG PHARMA as its R&D Institute. We cooperate with reliable partners both from China and foreign countries to contribute to human health. On the way to EU market, we are constantly seeking for new strategic partners.

企业简介

河北天成药业股份有限公司始建于1970年，是一家具有近50年历史的专业化制药企业。公司前身是国有企业，2010年3月改制为股份有限公司，是沧州市最大的综合性化学制药企业，同时也是河北省高新技术企业。公司各种剂型的药品享誉全国，大容量注射剂、小容量注射剂、粉针剂和片剂畅销于独联体、中亚、东南亚、南美洲和非洲等地区和国家，并拥有160余个国外注册证。

公司现有职工1000余人。可生产大容量注射剂、小容量注射剂、冲洗剂、粉针剂、原料药、片剂、颗粒剂等剂型的药品。年可生产大容量注射剂3.5亿瓶、玻璃安瓿瓶小容量注射剂4亿支、塑料安瓿瓶小容量注射剂4000万支、粉针剂3000万支、颗粒剂3亿袋、片剂15亿片以及中药提取物1400吨。公司一如既往的秉承“制好药为人民”的企业宗旨，已形成了集团化的战略发展布局，下设天成药业（制剂工厂）、道恩药业（抗癌药工厂）、诺特药业（原料药工厂）、天津应天成科技（药物研究院）。我们始终携手国内外合作伙伴来共同推动人类健康事业的发展，并在发展道路上不断寻求新的战略性合作伙伴。